Analysts Viewpoint
Chief Medical Officer Rodman David Malcom sale 11,366 shares of Mineralys Therapeutics Inc [MLYS]
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Mineralys Therapeutics
Mineralys Therapeutics Inc’s filing revealed that its Director Slingsby Brian Taylor acquired Company’s shares for reported $3.5 million on Mar
Mineralys Therapeutics Inc’s filing revealed that its Director Slingsby Brian Taylor acquired Company’s shares for reported $3.5 million on Mar
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or